<qa>  What is the name of the study that was produced by the British Columbia Cancer Agency?The objectives of this study are to document the safety and efficacy of 18F-FDG produced by the British Columbia Cancer Agency BCCA at its Tri-University Meson Facility TRIUMF production facility and to evaluate FDG-PET as a diagnostic and decision making tool in the management of oncology patients in British Columbia. With a population base of over 4 million people, standardized cancer treatment protocols, and evidence based guidelines for FDG-PET imaging, the BCCA is positioned to make an important contribution to defining the role of PET in the Canadian health care system. 